12 reports

Chapter One: Executive Summary ## Figure ##-## The Worldwide Market for Needle-free Drug Delivery Systems 2013-2020 Total Needle-free Drug Delivery Market by Technology The needle-free jet injector drug delivery market seg

  • Vaccine
  • United States
  • Market Size
  • Bioject Medical Technologies Inc.
  • Crossject

THE DEVICE WOULD ALSO ALLOW FOR A FULL YEAR OF DRUG DELIVERY WITH ONLY A SINGLE PLACEMENT.

  • Endocrine Disease
  • Type 2 Diabetes
  • Vaccine
  • United States
  • Market Size

Traditionally, a blockbuster drug is defined as one with annual sales of more than USD ## billion.

  • Vaccine
  • United States
  • Market Size
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.

GALENA BIOPHARMA GENEXINE Manufactures pharmaceutical products, new and generic medicines, and creates new methods of drug discovery and delivery.

  • Immunotherapy
  • Therapy
  • Vaccine
  • United States
  • Market Size

Similarly, Insulin delivery systems Pre-mixed insulins: Depend on product (drug); usually between ## minutes and ##- ## minutes before mealtime Short-acting insulins: ##-## minutes before a meal Intermediate-acting insulins: One hour prior to a meal The global

  • Vaccine
  • United States
  • Market Size
  • Boston Scientific Corporation
  • Medtronic, Inc.

THIS EMERGING FIELD OF DRUG DELIVERY IS STILL IN ITS INFANCY, WITH ONLY ONE MICRONEEDLE BASED DELIVERY DEVICE AVAILABLE COMMERCIALLY IN 2014.

  • Vaccine
  • United States
  • Market Size
  • Circassia Pharmaceuticals plc
  • Clearside Biomedical, Inc.

GALENA BIOPHARMA GENEXINE Manufactures pharmaceutical products, new and generic medicines, and creates new methods of drug discovery and delivery.

  • Immunotherapy
  • Therapy
  • Vaccine
  • United States
  • Market Size

HOWEVER, INTRAVESICAL DRUG DELIVERY REQUIRES CATHETERIZATION, WHICH PRESENTS RISKS ITSELF, INCLUDING RISK OF BLEEDING AND INFECTION.

  • Bladder Cancer
  • Therapy
  • Vaccine
  • United States
  • Market Size

ORAL TRANSMUCOSAL DRUG DELIVERY SYSTEMS HAVE RECENTLY GAINED A LOT OF ATTENTION; ONE OF THE KEY DRIVING FACTORS IS THE PREFERENCE FOR NON- INVASIVE ROUTES OF DRUG DELIVERY.

  • Vaccine
  • United States
  • Market Size
  • BioDelivery Sciences International, Inc.
  • MonoSol Rx, LLC

The encapsulation of phytogenic feed additives is one of the emerging technologies that help formulate suitable dosage form for drug delivery.

  • Vaccine
  • APAC
  • United States
  • Market Size
  • Sanofi S.A.

FURTHERMORE, NOVEL DRUG DELIVERY METHODS ARE ALSO BEING EVALUATED TO TARGET TRANSFORMED CELLS IN A MORE SPECIFIC MANNER.

  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • United States
  • Market Size

Food and Drug Administration.

  • Vaccine
  • United States
  • World
  • Market Size
  • CSL Limited